Invention Grant
- Patent Title: Human anti-α9 integrin antibody
- Patent Title (中): 人抗α9整联蛋白抗体
-
Application No.: US12810939Application Date: 2008-12-26
-
Publication No.: US08715655B2Publication Date: 2014-05-06
- Inventor: Masaharu Torikai , Daisuke Ishikawa , Toshihiro Nakashima , Hirofumi Higuchi , Fumihiko Sakai , Nobuchika Yamamoto , Hirotada Fujita , Katsunari Taguchi
- Applicant: Masaharu Torikai , Daisuke Ishikawa , Toshihiro Nakashima , Hirofumi Higuchi , Fumihiko Sakai , Nobuchika Yamamoto , Hirotada Fujita , Katsunari Taguchi
- Applicant Address: JP Kumamoto-shi
- Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
- Current Assignee: Juridical Foundation The Chemo-Sero-Therapeutic Research Institute
- Current Assignee Address: JP Kumamoto-shi
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP2007-340203 20071228
- International Application: PCT/JP2008/073825 WO 20081226
- International Announcement: WO2009/084671 WO 20090709
- Main IPC: A61K39/395
- IPC: A61K39/395 ; C07K16/00 ; C07K16/46 ; C07K16/28 ; G01N33/53

Abstract:
The present invention provides a human anti-α9 integrin antibody or an antibody fragment which specifically recognize human α9 integrin and mouse α9 integrin, inhibit interaction with their ligands, particularly, the antibody or antibody fragment which recognize loop regions of human and mouse α9 integrins, a gene encoding the antibody or antibody fragment, a recombinant expression vector containing the gene, a transformant harboring the gene, production method of human anti-α9 integrin antibody or antibody fragment using the transformant, and an agent for the prophylaxis or treatment of rheumatoid arthritis which contains the antibody or antibody fragment.
Public/Granted literature
- US20110014213A1 HUMAN ANTI-ALPHA 9 INTEGRIN ANTIBODY Public/Granted day:2011-01-20
Information query